FY26-pharmacy adempas march
Ended Awarded Last action
- Contract number
- 15B50926F00000065
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
Federal Correctional Institution Fort Worth
Correctional Facilities, Department of Justice
- Obligated
- $24,792
Award facts
- Contract value 100% obligated
- $24,792.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
About this award
Bayer Healthcare Pharmaceuticals Inc. was awarded a $24.8K firm fixed-price delivery order by the Federal Correctional Institution Fort Worth on March 1, 2026, with completion scheduled for March 31, 2026. This delivery order, designated "FY26-PHARMACY ADEMPAS MARCH," procures the pharmaceutical product Adempas (riociguat), used to treat pulmonary arterial hypertension, with performance at the vendor's Whippany, New Jersey facility. The award was issued without small business set-aside designation, consistent with Bayer Healthcare Pharmaceuticals Inc.'s classification as a large, foreign-owned pharmaceutical enterprise. This delivery order is issued under the parent contract Master GSA Schedule for Pharmaceuticals and Drugs (FSS-61-IB), an $840 million multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs that enables various federal agencies to procure pharmaceutical products at pre-negotiated pricing.
Bayer Healthcare Pharmaceuticals Inc., a subsidiary of Germany-based Bayer AG, has established itself as a critical supplier of specialized pharmaceutical products to the federal government since its SAM.gov registration in 2011. The company maintains significant indefinite delivery vehicles, including a recent $6.8 million Blanket Purchase Agreement with the VA National Acquisition Center effective through October 2026 specifically covering Xofigo and Adempas medications. Bayer's federal contracting portfolio reflects its specialized role in providing medications often available from limited manufacturers, with recurring task orders across Veterans Integrated Service Networks, Federal Medical Centers, the Defense Health Agency, and the Office of the Assistant Secretary for Preparedness and Response, supporting healthcare programs for veterans, active-duty military personnel, and other federal beneficiaries.
Quick answers
Who was awarded contract 15B50926F00000065?
15B50926F00000065 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Federal Correctional Institution Fort Worth (Correctional Facilities) on March 1, 2026.
How much is contract 15B50926F00000065 worth?
The government has obligated $24,792 on 15B50926F00000065.
Is contract 15B50926F00000065 an order under another contract?
Yes. 15B50926F00000065 is a delivery order under 36F79720D0237, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50926F00000065 competed?
The extent of competition for 15B50926F00000065 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award